Raleigh, NC (PRWEB) August 26, 2010
Agile Sciences announces today that the company has been awarded a $252,000 NIH Phase I SBIR grant to study the effectiveness of the company’s proprietary compounds to inhibit and disperse the oral biofilms of pathogenic bacteria associated with dental caries, or tooth decay.
Dental caries affects hundreds of millions of people each year, and is second only to the common cold in its prevalence world-wide. Caries is caused by acid-producing bacteria in the presence of carbohydrates, and these bacteria are particularly difficult to eradicate due to their ability to form oral biofilms, commonly known as plaque.
“We are delighted to now have the dedicated resources that will enable us to pursue this exciting application for our biofilm dispersion technology. Initial work indicates promise in dispersing these oral biofilms, so we are eager to validate that capability,” commented Dr. Christian Melander, co-founder of Agile Sciences.
About Agile Sciences:
Agile Sciences is headquartered on North Carolina State University's Centennial Campus, North Carolina. The company was founded in 2007 by Professors Christian Melander and John Cavanagh of North Carolina State University (NCSU) to provide commercial solutions to those industries plagued by the effects of biofilms. The company's proprietary compound was derived from the Agelas conifera sea sponge and has been shown to be effective in dispersing biofilms. For additional information, please visit: http://www.agilesci.com
###
We're here to help.
Call 1-866-640-6397
©Copyright 1997-, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
